Percutaneous Coronary Intervention (PCI) Clinical Trials

Clinical trials related to Percutaneous Coronary Intervention (PCI) Procedure

OPtimal TIming of Staged Complete RevascularizatiON in ST-Segment Elevation Myocardial Infarction With Multivessel Disease: The OPTION-STEMI2 Trial

Status: Recruiting
Location: See all (30) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This prospective, multicenter, open-label, superiority trial will enroll patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. Following successful percutaneous coronary intervention (PCI) of the infarct-related artery (IRA), patients who meet the eligibility criteria will be randomized in a 1:1 ratio to either in-hospital staged complete revascularization with PCI of non-IRA lesions performed on a separate day during hospitalization, at least 48 hours after PCI of the IRA, or out-of-hospital staged complete revascularization with PCI of non-IRA lesions performed after discharge between 15 and 45 days of randomization. In both groups, non-IRA lesions with 50-69% stenosis will be evaluated using FFR.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:

• Age ≥19 years

• ST-segment elevation myocardial infarction (STEMI): ST-segment elevation ≥ 0.1 mV in at least two contiguous leads, or New-onset left bundle branch block (LBBB)

• Primary PCI within 12 h after symptom development

• At least 1 non-infarct related artery (non-IRA) with diameter ≥ 2.5 mm and 50% stenosis by visual estimation

Locations
Other Locations
Republic of Korea
Bucheon Sejong Hospital
NOT_YET_RECRUITING
Bucheon-si
Gyeongsang National University Changwon Hospital
NOT_YET_RECRUITING
Changwon
Samsung Changwon Medical Center
NOT_YET_RECRUITING
Changwon
Soon Chun Hyang University Hospital Cheonan
NOT_YET_RECRUITING
Cheonan
Chungbuk National University Hospital
NOT_YET_RECRUITING
Cheongju-si
Kangwon National University Hospital
NOT_YET_RECRUITING
Chuncheon
Daegu Catholic University Medical Center
NOT_YET_RECRUITING
Daegu
Keimyung University Dongsan Hospital
NOT_YET_RECRUITING
Daegu
Kyungpook National University Hospital
NOT_YET_RECRUITING
Daegu
Yeongnam University Medical Center
NOT_YET_RECRUITING
Daegu
Chungnam National University Hospital
NOT_YET_RECRUITING
Daejeon
Chonnam National University Hospital
RECRUITING
Gwangju
Chosun University Hospital
NOT_YET_RECRUITING
Gwangju
Gwangju Veterans Hospital
NOT_YET_RECRUITING
Gwangju
Kwangju Christian Hospital
NOT_YET_RECRUITING
Gwangju
Chung-Ang University Gwangmyeong Hospital
NOT_YET_RECRUITING
Gwangmyeong
Jeju National University Hospital
NOT_YET_RECRUITING
Jeju City
Jeonbuk National University Hospital
NOT_YET_RECRUITING
Jeonju
Presbyterian Medical Center
NOT_YET_RECRUITING
Jeonju
Gyeongsang National University Hospital
NOT_YET_RECRUITING
Jinju
Inje University Busan Paik Hospital
NOT_YET_RECRUITING
Pusan
Inje University Haeundae Paik Hospital
NOT_YET_RECRUITING
Pusan
Kosin University Gospel Hospital
NOT_YET_RECRUITING
Pusan
Pusan National University Hospital
NOT_YET_RECRUITING
Pusan
Koera University Guro Hospital
NOT_YET_RECRUITING
Seoul
Korea University Anam Hospital
NOT_YET_RECRUITING
Seoul
Yonsei University Health System, Gangnam Severance Hospital
NOT_YET_RECRUITING
Seoul
St. Carollo General Hospital
NOT_YET_RECRUITING
Suncheon
Ajou University Hospital
NOT_YET_RECRUITING
Suwon
Pusan National University Yangsan Hospital
NOT_YET_RECRUITING
Yangsan
Contact Information
Primary
Min Chul Kim, MD, PhD
kmc3242@hanmail.net
82-10-4606-2643
Time Frame
Start Date: 2026-08-21
Estimated Completion Date: 2035-07-31
Participants
Target number of participants: 1252
Treatments
Experimental: In-hospital staged complete revascularization
In the in-hospital staged complete revascularization group, PCI of non-IRA lesions will be performed on a separate day during the index hospitalization, at least 48 hours after PCI of the IRA. Non-IRA lesion which have equal or more than 70% diameter stenosis by visual estimation will be revascularized without FFR evaluation. Non-IRA lesion with diameter stenosis 50-69% by visual estimation will be evaluated using FFR device. In case of FFR value more than 0.8, non-IRA lesion will be deferred without PCI. If FFR value was equal or less than 0.8, non-IRA lesion will be revascularized.
Active_comparator: Out-of-hospital staged complete revascularization
In the out-of-hospital staged complete revascularization group, PCI of non-IRA lesions will be performed after discharge and between 15 and 45 days of randomization. Non-IRA lesion which have equal or more than 70% diameter stenosis by visual estimation will be revascularized without FFR evaluation. Non-IRA lesion with diameter stenosis 50-69% by visual estimation will be evaluated using FFR device. In case of FFR value more than 0.8, non-IRA lesion will be deferred without PCI. If FFR value was equal or less than 0.8, non-IRA lesion will be revascularized.
Sponsors
Leads: Chonnam National University Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials